We are a science-led global healthcare company that researches and develops innovative Pharmaceuticals, Vaccines and Consumer Healthcare products. Our products are used by millions of people around the world, helping them to do more, feel better and live longer.
We have three primary areas of business in pharmaceuticals, vaccines and consumer healthcare. Our commercial success depends on creating innovative new products and making these accessible to as many people who need them as possible. By achieving this, we will be able to grow our business and provide benefits to patients, consumers, society, our employees and our shareholders.
Research is vitally important to the success of our business. We are one of the few healthcare companies researching medicines and vaccines for the World Health Organisation’s three priority diseases – HIV/AIDS, tuberculosis and malaria.
We have a significant global commercial presence in more than 150 markets, a network of 84 manufacturing sites, in 36 countries and large R&D centres in the UK, USA, Belgium and China. Since 2008 we have reshaped our global footprint to improve access to high growth potential markets including those in Asia Pacific, Latin America and Japan.